Characterization of Rift Valley Fever Virus MP-12 Strain Encoding NSs of Punta Toro Virus or Sandfly Fever Sicilian Virus

PLoS Neglected Tropical Diseases

Volumn 7, Issue 4, 2013, Pages

  Lihoradova, Olga A ^a   Indran, Sabarish V ^a   Kalveram, Birte ^a   Lokugamage, Nandadeva ^a   Head, Jennifer A ^a   Gong, Bin ^a,b   Tigabu, Bersabeh ^a   Juelich, Terry L ^a,b   Freiberg, Alexander N ^a,b   Ikegami, Tetsuro ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; RECOMBINANT VACCINE; RIFT VALLEY FEVER VIRUS MP 12 VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE REPRESSION; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; NORTHERN BLOTTING; RIFT VALLEY FEVER BUNYAVIRUS; SURVIVAL; VIRUS REPLICATION; WESTERN BLOTTING;

EID: 84876861361     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002181     Document Type: Article

References (66)

1. Swanepoel R, Coetzer JAW (2004) Rift Valley fever. In: Coetzer JAW, Tustin RC. Infectious diseases of livestock with special reference to southern Africa. 2nd edition. Cape Town, South Africa: Oxford University Press. pp.1037-1070.
2. Ikegami T, Makino S, (2011) The Pathogenesis of Rift Valley Fever. Viruses 3: 493-519.
3. Peters CJ, Meegan JM (1981) Rift Valley Fever. In: Handbook Series of Zoonoses, Section B: Viral Zoonoses. Vol. Boca Raton, FL: CRC Press. pp. 403-420.
4. Bird BH, Ksiazek TG, Nichol ST, Maclachlan NJ, (2009) Rift Valley fever virus. J Am Vet Med Assoc 234: 883-893.
5. Pepin M, Bouloy M, Bird BH, Kemp A, Paweska J, (2010) Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet Res 41: 61.
6. Linthicum KJ, Anyamba A, Tucker CJ, Kelley PW, Myers MF, et al. (1999) Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya. Science 285: 397-400.
7. Linthicum KJ, Davies FG, Kairo A, Bailey CL, (1985) Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus). Isolations from Diptera collected during an inter-epizootic period in Kenya. J Hyg 95: 197-209.
8. Davies FG, Linthicum KJ, James AD, (1985) Rainfall and epizootic Rift Valley fever. Bull World Health Organ 63: 941-943.
9. Zeller HG, Fontenille D, Traore-Lamizana M, Thiongane Y, Digoutte JP, (1997) Enzootic activity of Rift Valley fever virus in Senegal. Am J Trop Med Hyg 56: 265-272.
10. Daubney R, Hudson JR, (1931) Enzootic hepatitis or Rift Valley fever: An undescribed virus disease of sheep cattle and man from east Africa. J Path Bact 34: 545-579.
11. Grobbelaar AA, Weyer J, Leman PA, Kemp A, Paweska JT, et al. (2011) Molecular epidemiology of Rift Valley fever virus. Emerg Infect Dis 17: 2270-2276.
12. Bird BH, Githinji JW, Macharia JM, Kasiiti JL, Muriithi RM, et al. (2008) Multiple virus lineages sharing recent common ancestry were associated with a Large Rift Valley fever outbreak among livestock in Kenya during 2006-2007. J Virol 82: 11152-11166.
13. Bird BH, Khristova ML, Rollin PE, Ksiazek TG, Nichol ST, (2007) Complete genome analysis of 33 ecologically and biologically diverse Rift Valley fever virus strains reveals widespread virus movement and low genetic diversity due to recent common ancestry. J Virol 81: 2805-2816.
14. Carroll SA, Reynes JM, Khristova ML, Andriamandimby SF, Rollin PE, et al. (2011) Genetic evidence for Rift Valley fever outbreaks in Madagascar resulting from virus introductions from the East African mainland rather than enzootic maintenance. J Virol 85: 6162-6167.
15. Miller BR, Godsey MS, Crabtree MB, Savage HM, Al-Mazrao Y, et al. (2002) Isolation and genetic characterization of Rift Valley fever virus from Aedes vexans arabiensis, Kingdom of Saudi Arabia. Emerg Infect Dis 8: 1492-1494.
16. Shoemaker T, Boulianne C, Vincent MJ, Pezzanite L, Al-Qahtani MM, et al. (2002) Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen, 2000-01. Emerg Infect Dis 8: 1415-1420.
17. Roger M, Girard S, Faharoudine A, Halifa M, Bouloy M, et al. (2011) Rift valley fever in ruminants, Republic of Comoros, 2009. Emerg Infect Dis 17: 1319-1320.
18. USDA A, (2005) Part II. 7 CFR Part 331 and 9 CFR Part 121 Agricultural Bioterrorism Protection Act of 2002; Possesion, use, and transfer of biological agents and toxins; final rule. Fed Register 2005 70: 13241-13292.
19. Schmaljohn C, Nichol ST (2007) Bunyaviridae Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, editors. Fields Virology. 5th edition. Philadelphia, PA: Lippincott, Williams & Wilkins. pp.1741-1789.
20. Gerrard SR, Nichol ST, (2007) Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins. Virology 357: 124-133.
21. Giorgi C, Accardi L, Nicoletti L, Gro MC, Takehara K, et al. (1991) Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian Sandfly fever, and Uukuniemi viruses. Virology 180: 738-753.
22. Muller R, Poch O, Delarue M, Bishop DH, Bouloy M, (1994) Rift Valley fever virus L segment: correction of the sequence and possible functional role of newly identified regions conserved in RNA-dependent polymerases. J Gen Virol 75: 1345-1352.
23. Orphanides G, Lagrange T, Reinberg D, (1996) The general transcription factors of RNA polymerase II. Genes Dev 10: 2657-2683.
24. Giglia-Mari G, Coin F, Ranish JA, Hoogstraten D, Theil A, et al. (2004) A new, tenth subunit of TFIIH is responsible for the DNA repair syndrome trichothiodystrophy group A. Nat Genet 36: 714-719.
25. Schultz P, Fribourg S, Poterszman A, Mallouh V, Moras D, et al. (2000) Molecular structure of human TFIIH. Cell 102: 599-607.
26. Drapkin R, Reardon JT, Ansari A, Huang JC, Zawel L, et al. (1994) Dual role of TFIIH in DNA excision repair and in transcription by RNA polymerase II. Nature 368: 769-772.
27. Iben S, Tschochner H, Bier M, Hoogstraten D, Hozak P, et al. (2002) TFIIH plays an essential role in RNA polymerase I transcription. Cell 109: 297-306.
28. Le May N, Dubaele S, Proietti De Santis L, Billecocq A, Bouloy M, et al. (2004) TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 116: 541-550.
29. Kalveram B, Lihoradova O, Ikegami T, (2011) NSs Protein of Rift Valley Fever Virus Promotes Post-Translational Downregulation of the TFIIH Subunit p62. J Virol 85: 6234-6243.
30. Billecocq A, Spiegel M, Vialat P, Kohl A, Weber F, et al. (2004) NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol 78: 9798-9806.
31. Le May N, Mansuroglu Z, Leger P, Josse T, Blot G, et al. (2008) A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. PLoS Pathog 4: e13.
32. Ikegami T, Narayanan K, Won S, Kamitani W, Peters CJ, et al. (2009) Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog 5: e1000287.
33. Ikegami T, Narayanan K, Won S, Kamitani W, Peters CJ, et al. (2009) Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR. Ann N Y Acad Sci 1171 Suppl 1: E75-85.
34. Habjan M, Pichlmair A, Elliott RM, Overby AK, Glatter T, et al. (2009) NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J Virol 83: 4365-4375.
35. Caplen H, Peters CJ, Bishop DH, (1985) Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J Gen Virol 66: 2271-2277.
36. Lokugamage N, Freiberg AN, Morrill JC, Ikegami T, (2012) Genetic Subpopulations of Rift Valley Fever ZH548, MP-12 and Recombinant MP-12 Strains. J Virol 86: 13566-13575.
37. Peters CJ (1997) Emergence of Rift Valley fever. Factors in the Emergence of Arbovirus Diseases. Paris: Elsevier. pp. 253-264.
38. Morrill JC, Carpenter L, Taylor D, Ramsburg HH, Quance J, et al. (1991) Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep. Vaccine 9: 35-41.
39. Morrill JC, Jennings GB, Caplen H, Turell MJ, Johnson AJ, et al. (1987) Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes. Am J Vet Res 48: 1042-1047.
40. Morrill JC, Mebus CA, Peters CJ, (1997) Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids. Am J Vet Res 58: 1110-1114.
41. Morrill JC, Mebus CA, Peters CJ, (1997) Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle. Am J Vet Res 58: 1104-1109.
42. Habjan M, Penski N, Spiegel M, Weber F, (2008) T7 RNA polymerase-dependent and-independent systems for cDNA-based rescue of Rift Valley fever virus. J Gen Virol 89: 2157-2166.
43. Moutailler S, Roche B, Thiberge JM, Caro V, Rougeon F, et al. (2011) Host alternation is necessary to maintain the genome stability of rift valley fever virus. PLoS Negl Trop Dis 5: e1156.
44. Muller R, Saluzzo JF, Lopez N, Dreier T, Turell M, et al. (1995) Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. Am J Trop Med Hyg 53: 405-411.
45. Lihoradova O, Kalveram B, Indran SV, Lokugamage N, Juelich TL, et al. (2012) The Dominant-Negative Inhibition of Double-Stranded RNA-Dependent Protein Kinase PKR Increases the Efficacy of Rift Valley Fever Virus MP-12 Vaccine. J Virol 86: 7650-7661.
46. Xu F, Chen H, Travassos da Rosa AP, Tesh RB, Xiao SY, (2007) Phylogenetic relationships among sandfly fever group viruses (Phlebovirus: Bunyaviridae) based on the small genome segment. J Gen Virol 88: 2312-2319.
47. Gori Savellini G, Weber F, Terrosi C, Habjan M, Martorelli B, et al. (2010) Toscana virus induces interferon although its NSs protein reveals antagonistic activity. J Gen Virol 92: 71-79.
48. Perrone LA, Narayanan K, Worthy M, Peters CJ, (2007) The S segment of Punta Toro virus (Bunyaviridae, Phlebovirus) is a major determinant of lethality in the Syrian hamster and codes for a type I interferon antagonist. J Virol 81: 884-892.
49. Yang YL, Reis LF, Pavlovic J, Aguzzi A, Schafer R, et al. (1995) Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J 14: 6095-6106.
50. Ito N, Takayama-Ito M, Yamada K, Hosokawa J, Sugiyama M, et al. (2003) Improved recovery of rabies virus from cloned cDNA using a vaccinia virus-free reverse genetics system. Microbiol Immunol 47: 613-617.
51. Ikegami T, Won S, Peters CJ, Makino S, (2006) Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol 80: 2933-2940.
52. Kalveram B, Lihoradova O, Indran SV, Lokugamage N, Head JA, et al. (2013) Rift Valley fever virus NSs inhibits host transcription independently of the degradation of dsRNA-dependent protein kinase PKR. Virology 435: 415-424.
53. Morrill JC, Ikegami T, Yoshikawa-Iwata N, Lokugamage N, Won S, et al. (2010) Rapid accumulation of virulent rift valley Fever virus in mice from an attenuated virus carrying a single nucleotide substitution in the m RNA. PLoS ONE 5: e9986.
54. Lin R, Genin P, Mamane Y, Hiscott J, (2000) Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. Mol Cell Biol 20: 6342-6353.
55. Ehrhardt C, Kardinal C, Wurzer WJ, Wolff T, von Eichel-Streiber C, et al. (2004) Rac1 and PAK1 are upstream of IKK-epsilon and TBK-1 in the viral activation of interferon regulatory factor-3. FEBS Lett 567: 230-238.
56. Fredericksen B, Akkaraju GR, Foy E, Wang C, Pflugheber J, et al. (2002) Activation of the interferon-beta promoter during hepatitis C virus RNA replication. Viral Immunol 15: 29-40.
57. Ikegami T, Won S, Peters CJ, Makino S, (2005) Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment. J Virol 79: 12106-12111.
58. Kalveram B, Lihoradova O, Indran SV, Ikegami T, (2011) Using reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacy. J Vis Exp pp. e3400.
59. Diaz MO, Ziemin S, Le Beau MM, Pitha P, Smith SD, et al. (1988) Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci U S A 85: 5259-5263.
60. Mosca JD, Pitha PM, (1986) Transcriptional and posttranscriptional regulation of exogenous human beta interferon gene in simian cells defective in interferon synthesis. Mol Cell Biol 6: 2279-2283.
61. Jao CY, Salic A, (2008) Exploring RNA transcription and turnover in vivo by using click chemistry. Proc Natl Acad Sci U S A 105: 15779-15784.
62. Narayanan K, Huang C, Lokugamage K, Kamitani W, Ikegami T, et al. (2008) Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells. J Virol 82: 4471-4479.
63. Balachandran S, Beg AA, (2011) Defining emerging roles for NF-kappaB in antivirus responses: revisiting the interferon-beta enhanceosome paradigm. PLoS Pathog 7: e1002165.
64. Hiscott J, Pitha P, Genin P, Nguyen H, Heylbroeck C, et al. (1999) Triggering the interferon response: the role of IRF-3 transcription factor. J Interferon Cytokine Res 19: 1-13.
65. Hunter P, Erasmus BJ, Vorster JH, (2002) Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep. Onderstepoort J Vet Res 69: 95-98.
66. Nichol ST, Beaty BJ, Elliott RM, Goldbach RW, Plyusnin A, et al. (2005) The Bunyaviridae. In: Virus Taxonomy: VIIIth report of the international committee on taxonomy of viruses. Academic Press. pp. 695-716.